Nicholas Lydon's most recent trade in Blueprint Medicines Corp was a trade of 4,570 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Nicholas Lydon | Director | 12 Jun 2024 | 4,570 | 4,570 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 12 Jun 2024 | 2,242 | 58,026 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 21 Jun 2023 | 5,300 | 5,300 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 21 Jun 2023 | 2,600 | 55,784 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 21 Jun 2022 | 5,300 | 5,300 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 21 Jun 2022 | 2,600 | 53,184 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 23 May 2022 | 10,909 | 0 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 23 May 2022 | 10,909 | 50,584 (0%) | 0% | 19.5 | 213,053 | Common Stock | |
| Blueprint Medicines Corp | Nicholas Lydon | Director | 02 Jun 2021 | 4,500 | 4,500 | - | - | Stock Option (Right to Buy) | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 02 Jun 2021 | 2,250 | 39,675 (0%) | 0% | 0 | Common Stock | ||
| Blueprint Medicines Corp | Nicholas Lydon | Director | 01 Oct 2020 | 4,530 | 38,814 (0%) | 0% | 92.9 | 420,746 | Common Stock | |
| Blueprint Medicines Corp | Nicholas Lydon | Director | 01 Oct 2020 | 3,896 | 43,344 (0%) | 0% | 93.7 | 364,977 | Common Stock | |
| Blueprint Medicines Corp | Nicholas Lydon | Director | 01 Oct 2020 | 1,389 | 37,425 (0%) | 0% | 92.1 | 127,871 | Common Stock | |
| Blueprint Medicines Corp | Nicholas Lydon | Director | 17 Sep 2020 | 500 | 47,240 (0%) | 0% | 80 | 40,000 | Common Stock |